Undervalued Stocks Based On Cash Flows

Results

695

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

695 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
NTRA
US$271.454.4%68.0%US$38.9bUS$262.6715.558.0%n/aPharmaceuticals & Biotech
GOFORE
€9.78-1.4%-44.4%€158.8m€15.0019.732.8%5.0%Software
DCOM
US$40.652.2%46.6%US$1.8bUS$43.801.327.3%2.5%Banks
1021
HK$18.15-9.9%n/aHK$9.9bHK$26.5422.187.8%n/aCapital Goods
CNOB
US$33.441.1%39.0%US$1.7bUS$34.601.134.7%2.3%Banks
R3NK
€42.18-7.8%-34.3%€4.2b€67.9336.724.4%1.4%Capital Goods
CDON
SEK 60.00-4.8%21.7%SEK 688.0mSEK 90.001.582.6%n/aRetail
ENEA
SEK 74.10-1.9%5.1%SEK 1.4bSEK 92.5016.023.7%0%Software
INTA
US$25.2115.0%-48.4%US$1.9bUS$33.713.5117.4%n/aSoftware
ALNY
US$301.034.5%-6.5%US$39.2bUS$434.7274.727.9%n/aPharmaceuticals & Biotech
CGS
AU$2.69-2.2%58.2%AU$463.8mAU$3.1829.224.5%0.7%Healthcare
PNV
AU$0.940%-20.8%AU$635.6mAU$1.7065.431.0%n/aHealthcare
CMT
د.م4,550.00-5.2%96.0%د.م7.6bد.م4,469.0038.927.4%0%Materials
MSAB B
SEK 69.60-2.0%32.3%SEK 1.3bSEK 78.2527.929.3%2.3%Software
6990
HK$436.209.6%33.3%HK$101.7bHK$547.6442.844.8%n/aPharmaceuticals & Biotech
BBT
US$30.450.7%16.9%US$2.6bUS$32.831.042.3%4.2%Banks
MAD
AU$8.184.6%19.1%AU$1.6bAU$9.4827.012.7%1.2%Commercial Services
CTEC
UK£2.154.0%-21.0%UK£4.2bUK£3.0131.820.0%2.5%Healthcare
TFII
CA$204.15-0.5%67.0%CA$16.9bCA$216.5539.729.1%1.3%Transportation
TSTL
UK£4.002.6%0%UK£191.9mUK£4.7524.414.6%3.6%Healthcare
CBHB
RM 0.696.2%179.6%RM 1.3bRM 0.7121.39.6%0.4%Capital Goods
605056
CN¥15.96-8.4%6.3%CN¥6.6bn/a24.731.1%2.4%Capital Goods
WAYS
SEK 38.90-1.5%8.1%SEK 341.1mSEK 59.0056.053.2%0%Tech
JST
€52.00-4.2%-2.8%€852.3m€75.0074.744.0%2.9%Capital Goods
Page 1 of 20